Abstract:Background The association between menopause, changes in body composition, and nonalcoholic fatty liver disease is not clear, and there is a lack of weight management strategies for perimenopausal women from the perspective of preventing nonalcoholic fatty liver disease. Methods A total of 1316 postmenopausal and 3049 premenopausal women in the Kailuan cohort in China between 2006 and 2017 were enrolled and followed up till 2021. Cox regression models, including the causal mediation analyses, were used to estimate the association between menopause and nonalcoholic fatty liver disease and the potential mediation effect of changes in body composition. We also explored the impact of weight changes on the correlation between menopause and nonalcoholic fatty liver disease. Results Women who experienced menopause had a higher risk of nonalcoholic fatty liver disease than premenopausal women (9-year cumulative incidence: 56.87 % vs. 48.80 %, adjusted hazard ratio = 1.219, 95 % confidence interval: 1.088–1.365). The nine-year cumulative incidence of nonalcoholic fatty liver disease was higher among overweight/obese postmenopausal women (67.24 % vs. 45.74 %, P < 0.001) and those with abdominal obesity (63.36 % vs. 49.69 %, P < 0.001); however, the hazard ratio of menopause for nonalcoholic fatty liver disease was more evident in women with a body mass index under 23.0 kg/m2 (hazard ratio = 1.434, 95 % confidence interval: 1.168–1.759) and those with normal waist circumference (hazard ratio = 1.362, 95 % confidence interval: 1.129–1.643), which could partially be explained by the visceral fat index (7.09 % and 7.35 % mediation, respectively). Weight loss of 3 % or more or reduction in waist circumference by 5 % or more was associated with a 31.1 % reduction (95 % confidence interval, 20.8 %–40.0 %) or a 14.2 % reduction (95 % confidence interval, 1.1 %–25.6 %) in the risk of nonalcoholic fatty liver disease among the premenopausal women. For postmenopausal women, weight gain of 3 % or more was associated with an increased risk of nonalcoholic fatty liver disease, especially in individuals with a body mass index under 23.0 kg/m2. Conclusion Menopause was associated with a higher risk of nonalcoholic fatty liver disease, partially by increasing visceral fat. Controlling weight in perimenopausal women may reduce the risk.

[Research progress of non-alcoholic fatty liver disease in postmenopausal women]

Protective effect of phytoestrogens on nonalcoholic fatty liver disease in postmenopausal women

Research Progress on the Mechanism of Traditional Chinese Medicine in the Treatment of Non-Alcoholic Fatty Liver Disease Based on Oxidative Stress

Recent Progress of Proteomics in Nonalcoholic Fatty Liver Disease*

The Effect of Menopausal Status, Insulin Resistance and Body Mass Index on the Prevalence of Non-Alcoholic Fatty Liver Disease

The advantages of physical exercise as a preventive strategy against NAFLD in postmenopausal women

The Latest Research Progress of Non-alcoholic Fatty Liver Disease-related Hepatocellular Carcinoma

Sex-specific Metabolic Risk Factors and Their Trajectories Towards the Non-Alcoholic Fatty Liver Disease Incidence.

[Research Advances in Diagnosis of Non-Alcoholic Fatty Liver Disease].

Association of Age at First Birth and Risk of Non-Alcoholic Fatty Liver Disease in Women: Evidence from the NHANES

Progress in Non-invasive Diagnosis and Assessment of Non-alcoholic Fatty Liver Disease

Non-alcoholic Fatty Liver Disease: the Problems We Are Facing.

Serum Retinol Binding Protein 4 and Galectin-3 Binding Protein As Novel Markers for Postmenopausal Nonalcoholic Fatty Liver Disease.

Research Progress on the Mechanism of Acupuncture Treatment for Nonalcoholic Fatty Liver Disease

Features of the course of non-alcoholic fatty liver disease in women at different age periods: literature review

Current status of research on nonalcoholic fatty liver disease in China

Association Between Menopause, Body Composition, and Nonalcoholic Fatty Liver Disease: A Prospective Cohort in Northern China

Research Advances in Extrahepatic Diseases Associated with Nonalcoholic Fatty Liver Disease

Nonalcoholic Fatty Liver Disease Shows Significant Sex Dimorphism

Recent Advances in Adipose Tissue Dysfunction and Its Role in the Pathogenesis of Non-Alcoholic Fatty Liver Disease

Research advances in non-alcoholic fatty liver disease: a review of current status and prospect